CLINICAL, MORPHOLOGICAL, AND EPIDEMIOLOGICAL CHARACTERISTICS OF ENDOMETRIAL HYPERPLASTIC PROCESSES IN SUMY REGION
DOI:
https://doi.org/10.21272/eumj.2021;9(4):342-351Keywords:
endometrial hyperplasia, endometrial polyps, morbidity, classification, diagnostics, statisticsAbstract
Endometrial hyperplastic processes take an important place among the gynecological diseases in women of various ages and are one of the most common reasons for admission at inpatient gynecology departments. The urgency of the pathology is due to the significant prevalence of endometrial hyperplastic processes, high incidence of malignancy, prolonged relapsing course, and decreased reproductive function, since these diseases are one of the most common causes of infertility in women of childbearing age. The statistics related to the incidence of endometrial hyperplastic processes in Ukraine is not available. An analysis of case histories and medical records showed that in 40% of cases, endometrial hyperplastic processes were asymptomatic. In 60% of cases, the clinical manifestations of endometrial hyperplastic processes were menstrual disorders, such as dysmenorrhea, oligomenorrhea, menorrhagia, and metrorrhagia. In 30% of cases, endometrial hyperplastic processes were recurrent. The most common concomitant pathologies of the pelvic organs were uterine leiomyoma and endometriosis; the most common concomitant extragenital diseases were hypertension and obesity. Our study and data analysis showed that there is an increasing trend in the incidence of endometrial hyperplastic processes in Sumy region in 2011–2020. The maximum incidence was in 2016. A correlation was found between hyperplasia incidence and age. Thus, the largest number of non-atypical and atypical endometrial hyperplasia cases was observed in women aged 45–55 years. The lowest number of non-atypical endometrial hyperplasia cases was registered in women aged 66+, while atypical hyperplasia cases – in women under 30 years of age. Glandular polyps of the endometrium were most often diagnosed at the age of 31–44; the lowest number of these was found in women over 66 years. Most glandular-fibrous endometrial polyps were observed in women aged 45–55 years, while women under 30 presented with the fewest cases. Fibrous endometrial polyps were most common in older age groups – 66+; the lowest number of such endometrial polyps was found in women under 30 years. We attributed the decreased incidence of endometrial hyperplastic processes in 2020 to the quarantine measures introduced, which, as a consequence, led to the decreased number of diagnosed cases, since they are often asymptomatic.
Downloads
References
Travaglino A, Raffone A, Saccone G, et al. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review. Acta Obstet Gynecol Scand. 2019;98(9):1086-1099. doi:10.1111/aogs.13587
Doherty MT, Sanni OB, Coleman HG, et al. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis. PLoS One. 2020;15(4). doi:10.1371/journal.pone.0232231
Giannella L, Cerami LB, Setti T, Bergamini E, Boselli F. Prediction of Endometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding. Biomed Res Int. 2019;2019. doi:10.1155/2019/8598152
Hutt S, Tailor A, Ellis P, Michael A, Butler-Manuel S, Chatterjee J. The role of biomarkers in endometrial cancer and hyperplasia: a literature review. Acta Oncol. 2019;58(3):342-352. doi:10.1080/0284186X.2018.1540886
Giannella L, Carpini GD, Sopracordevole F, et al. Atypical endometrial hyperplasia and unexpected cancers at final histology: A study on endometrial sampling methods and risk factors. Diagnostics. 2020;10(7). doi:10.3390/diagnostics10070474
Yuksel S, Tuna G, Celik HG, Salman S. Endometrial polyps: Is the prediction of spontaneous regression possible? Obstet Gynecol Sci. 2021;64(1):114-121. doi:10.5468/OGS.20242
Adomaitienė L, Nadišauskienė R, Nickkho-Amiry M, et al. Proliferation in postmenopausal endometrial polyps—A potential for malignant transformation. Med. 2019;55(9). doi:10.3390/medicina55090543
Nakaz MOZ Ukrainy vid 05.05.2021 № 869 "Pro zatverdzhennia Unifikovanoho klinichnoho protokolu pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysoko-spetsializovanoi) medychnoi dopomohy «Hiperplaziia endometriia»
Sobczuk K, Sobczuk A. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications. Prz Menopauzalny. 2017;16(3):107-111. doi:10.5114/pm.2017.70589
Sanderson PA, Critchley HOD, Williams ARW, Arends MJ, Saunders PTK. New concepts for an old problem: The diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017;23(2):232-254. doi:10.1093/humupd/dmw042
Williams K, Ko E. Endometrial hyperplasia. In: Handbook of Gynecology. Vol 2. Springer International Publishing; 2017:877-891. doi:10.1007/978-3-319-17798-4_3
Auclair MH, Yong PJ, Salvador S, Thurston J, Colgan T (Terry) J, Sebastianelli A. Guideline No. 390-Classification and Management of Endometrial Hyperplasia. J Obstet Gynaecol Canada. 2019;41(12):1789-1800. doi:10.1016/j.jogc.2019.03.025
Bocca SM. Endometrial polyps. In: Ultrasound Imaging in Reproductive Medicine: Advances in Infertility Work-Up, Treatment, and Art. Springer New York; 2014:133-149. doi:10.1007/978-1-4614-9182-8_11
Nijkang NP, Anderson L, Markham R, Manconi F. Endometrial polyps: Pathogenesis, sequelae and treatment. SAGE Open Med. 2019;7:205031211984824. doi:10.1177/2050312119848247
Tanos V, Berry KE, Seikkula J, et al. The management of polyps in female reproductive organs. Int J Surg. 2017;43:7-16. doi:10.1016/j.ijsu.2017.05.012
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Nataliia L. Tsyndrenko, Anatolii M. Romaniuk, Yana R. Nikolayenko

This work is licensed under a Creative Commons Attribution 4.0 International License.

























